 Longterm cyclosporine therapy rheumatoid arthritis Sixteen patients good clinical response therapy randomized double blind study cyclosporine D-penicillamine active rheumatoid arthritis opportunity open study cyclosporine initial daily dose cyclosporine mg/kg maximal duration months premature discontinuations inefficacy side effects reasons study improvement clinical variables strict conditions trial irreversible loss renal function Suggestions chance nephrotoxicity